US equities
|
NVDA
$237.60
▲+1.56%
SPCX
$168.26
▲+5.85%
MU
$1,063.77
▼-1.03%
TSLA
$379.51
▲+2.41%
MSFT
$524.87
▲+1.42%
SNDK
$1,713.21
▼-0.39%
INTC
$116.86
▼-2.07%
META
$742.44
▲+1.97%
NVDA
$237.60
▲+1.56%
SPCX
$168.26
▲+5.85%
MU
$1,063.77
▼-1.03%
TSLA
$379.51
▲+2.41%
MSFT
$524.87
▲+1.42%
SNDK
$1,713.21
▼-0.39%
INTC
$116.86
▼-2.07%
META
$742.44
▲+1.97%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Globus Medical, Inc. Class A Common Stock
(NY:
GMED
)
76.77
+1.17 (+1.55%)
Delayed Quote
Updated: 2:04 PM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Globus Medical, Inc. Class A Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
1 Mid-Cap Stock for Long-Term Investors and 2 We Ignore
September 29, 2026
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. Howe...
Via
StockStory
2 Reasons to Watch GMED and 1 to Stay Cautious
September 28, 2026
Over the last six months, Globus Medical’s shares have sunk to $74.94, producing a disappointing 10.3% loss - a stark contrast to the S&P 500’s 21.4% gain. T...
Via
StockStory
Topics
Stocks
Q2 Earnings Highs And Lows: Globus Medical (NYSE:GMED) Vs The Rest Of The Medical Devices & Supplies - Specialty Stocks
September 23, 2026
As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - specialty industry, including Gl...
Via
StockStory
3 Profitable Stocks on Our Watchlist
September 18, 2026
Profitable companies tend to be more resilient, giving them the flexibility to invest and return capital to shareholders. Businesses that consistently genera...
Via
StockStory
Globus Medical (NYSE:GMED): A Decent Value Stock With Solid Fundamentals
↗
August 21, 2026
Via
Chartmill
Globus Medical (NYSE:GMED): A Compelling Affordable Growth Opportunity
↗
August 08, 2026
Via
Chartmill
Globus Medical (NYSE:GMED) Shares Rise on Q2 Earnings Beat and Raised Profit Guidance
↗
August 06, 2026
Via
Chartmill
Topics
Earnings
Globus Medical (GMED) Emerges as a Decent Value Stock with Strong Fundamentals
↗
July 30, 2026
Via
Chartmill
1 of Wall Street’s Favorite Stocks on Our Watchlist and 2 Facing Challenges
September 17, 2026
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic...
Via
StockStory
Globus Medical Announces CE Mark for Excelsius3D™ Imaging System
September 03, 2026
Excelsius3D™ – Intelligent 3-in-1 Imaging System Expands Excelsius™ Ecosystem in the European Union
From
Globus Medical
Via
GlobeNewswire
1 Growth Stock to Stash and 2 We Turn Down
September 03, 2026
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 wil...
Via
StockStory
Globus Medical Announces Acquisition of Higgs Boson Health to Transform Healthcare Experience Through AI-Driven Digital Solutions
August 26, 2026
From
Globus Medical
Via
GlobeNewswire
Globus Medical Inc - A (NYSE:GMED) Screens Well as a GARP Stock with Strong Growth and Reasonable Valuation
↗
July 10, 2026
Via
Chartmill
Globus Medical (NYSE:GMED) Shines in Navellier’s Little Book Growth Stock Screen
↗
July 03, 2026
Via
Chartmill
Globus Medical Inc - A (NYSE:GMED) Passes the Caviar Cruise Quality Stock Screener with Flying Colors
↗
June 20, 2026
Via
Chartmill
Globus Medical Q2 Earnings Call Highlights
↗
August 08, 2026
Globus Medical (NYSE:GMED) reported second-quarter 2026 revenue of $789.6 million, up 6% from a year earlier, as growth in its spine and trauma businesses helped offset declines in enabling...
Via
MarketBeat
Topics
Earnings
Globus Medical (NYSE:GMED) Beats Q2 CY2026 Sales Expectations
August 06, 2026
Medical device company Globus Medical (NYSE:GMED) announced better-than-expected revenue in Q2 CY2026, with sales up 5.9% year on year to $789.6 million. The...
Via
StockStory
Globus Medical Reports Second Quarter 2026 Results
August 06, 2026
From
Globus Medical
Via
GlobeNewswire
What To Expect From Globus Medical’s (GMED) Q2 Earnings
August 04, 2026
Medical device company Globus Medical (NYSE:GMED) will be announcing earnings results this Thursday afternoon. Here’s what you need to know. Globus Medical b...
Via
StockStory
Globus Medical Inc - A (NYSE:GMED) Screens as an Affordable Growth Opportunity with Solid Fundamentals
↗
June 13, 2026
Via
Chartmill
Globus Medical (NYSE:GMED) Shines in Navellier's Little Book Growth Stock Screen
↗
June 11, 2026
Via
Chartmill
3 Medical Device Stocks Giving Investors a Different Healthcare Play
↗
July 20, 2026
Globus Medical, Inspire Medical Systems, and Penumbra show varied revenue growth and analyst ratings, offering medical device investors alternatives to traditional pharmaceutical stocks.
Via
MarketBeat
2 Cash-Heavy Stocks with Exciting Potential and 1 We Avoid
July 20, 2026
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion o...
Via
StockStory
Topics
Retirement
STAAR Surgical, Globus Medical, Integer Holdings, and Enovis Stocks Trade Down, What You Need To Know
July 17, 2026
What Happened? A number of stocks fell in the afternoon session after a key industry player warned that changes to some insurance plans could slow U.S. proce...
Via
StockStory
Globus Medical Schedules Second Quarter Earnings Release and Conference Call
July 16, 2026
From
Globus Medical
Via
GlobeNewswire
3 Cash-Heavy Stocks to Target This Week
June 16, 2026
A clean balance sheet can signal disciplined management and stability. It also means a company can expand and thrive without relying on borrowed capital. Fin...
Via
StockStory
Topics
Initial Public Offering
1 Profitable Stock with Solid Fundamentals and 2 Facing Headwinds
June 08, 2026
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...
Via
StockStory
Topics
Retirement
2 Reasons to Watch GMED and 1 to Stay Cautious
June 08, 2026
Over the past six months, Globus Medical’s shares (currently trading at $79.99) have posted a disappointing 10.1% loss, well below the S&P 500’s 10.7% gain. ...
Via
StockStory
Topics
Stocks
2 Mid-Cap Stocks with Exciting Potential and 1 Facing Challenges
June 05, 2026
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. Howe...
Via
StockStory
Medical Devices & Supplies - Specialty Stocks Q1 Teardown: Globus Medical (NYSE:GMED) Vs The Rest
May 31, 2026
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a...
Via
StockStory
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
